The beneficial activities of LactoSpore® in various conditions like gastroenteritis or irritable bowel syndrome may be attributed to the following factors:

Improves Gut Microflora

Probiotics are known to stimulate the growth of other beneficial bacteria like Faecalibacterium prausnitzii in the human gut. Thus, establishment of healthy microflora eventually helps in reducing toxins as well as the growth of other bacterial/viral pathogens. This proves beneficial in the treatment/management of diseases like irritable bowel syndrome, which is attributed to a disrupted gut flora. In addition, probiotics also facilitate elimination of acids, antibiotics and other substances that might compete for colonisation sites and nutrients (Keller et al., 2010).

Production of Short-chain Fatty Acids

Probiotic strains can produce short-chain fatty acids (SCFAs), the benefits of which have been summarized in the figure below (Kasińska and Drzewoski, 2015).

Lactospore Mechanism

Studies indicate that LactoSpore® can produce various SCFAs (acetate, butyrate and propionate) by fermenting plant-based fibers (Trigonella foenum-graecum, Lycium barbarum, Linum usitatissimum, Cocos nucifera, Zingiber officinale, Emblica  officinalis, Plantago ovata and Vaccinium oxycoccos) (Majeed et al. 2016).